2016 Emerging Opportunities in the US HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.
Summary
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag /HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks - Physician Offices - Public Health LaboratoriesIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
HIghlights
Summary
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag /HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks - Physician Offices - Public Health LaboratoriesIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
HIghlights
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
I. INTRODUCTION
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech /Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech /Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
USA: HIV Ag Test Volume and Sales Forecasts By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
USA: HIV Ag Test Volume and Sales Forecasts By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers